Related Experiment Videos
Oxygen consumption by granulation tissue in bipedicle tube flaps.
Scandinavian Journal of Plastic and Reconstructive Surgery
|January 1, 1975
Summary
The oxygen consumption rate of granulation tissue in rabbit flaps decreased over 7 weeks. Control tissue showed higher oxygen consumption than flap tissue at most time points.
Area of Science:
- Tissue engineering
- Wound healing
- Biomaterials science
Background:
- Granulation tissue is crucial for wound healing and tissue regeneration.
- Understanding its metabolic activity, specifically oxygen consumption, is vital for assessing tissue viability.
- Implanted biomaterials influence the host tissue response and metabolic function.
Purpose of the Study:
- To investigate the oxygen consumption rate (QO2) of granulation tissue within bipedicle tube flaps in rabbits.
- To compare the QO2 of granulation tissue in flaps with control granulation tissue from skin folds.
- To evaluate metabolic changes in granulation tissue over a 7-week period.
Main Methods:
- Granulation tissue was harvested from implanted cylinders in rabbit bipedicle tube flaps and control skin folds.
- Oxygen consumption rate (QO2) was measured in vitro using a Biological Oxygen Monitor.
- Measurements were taken weekly from week 2 to week 7 post-implantation.
- All assays were conducted at a controlled oxygen tension of 75 mmHg.
Main Results:
- The QO2 of granulation tissue in flaps was initially high at week 2 and decreased significantly by week 7.
- A notable decrease in QO2 occurred between weeks 2-4 and again between weeks 6-7 in flap tissue.
- Control granulation tissue consistently exhibited a higher QO2 compared to flap granulation tissue at weeks 3, 4, 5, and 7.
Conclusions:
- The metabolic activity of granulation tissue in bipedicle tube flaps declines substantially over a 7-week period.
- The bipedicle tube flap environment may impose metabolic stress on granulation tissue compared to a standard skin fold environment.
- These findings highlight the importance of oxygen supply and metabolic assessment in engineered tissues and flap viability.